Tang Chun Wai Nelson
@Nan Fung Group Holdings Ltd
Latest period2024 - Q3ReportedManaged Assets$116.07MTotal holdings38
Assets growth rate23.84%Assets growth rate (2-Q avg)5.35%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Nan Fung Group Holdings Ltd's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 38 positions.
Assets under management
The assets under management (AUM) of Nan Fung Group Holdings Ltd over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 116.07M in assets, with a quarterly growth rate of 23.84% and a 2-quarter average growth rate of 5.35%. The portfolio is managed by Tang Chun Wai Nelson, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
ATHAAthira Pharma Inc
| 0% | $477,000 180,000 shares@ $2.65 avg price | Exited |
PACBPacific Biosciences Calif In
| 0% | $376,049 274,488 shares@ $1.38 avg price | Exited |
CABACabaletta Bio Inc
| 0% | $352,682 47,150 shares@ $7.48 avg price | Exited |
ROIVRoivant Sciences Ltd
| 0% | $343,208 32,470 shares@ $10.58 avg price | Exited |
GRALGrail Inc
| 0% | $305,340 19,866 shares@ $15.37 avg price | Exited |
IMCRImmunocore Hldgs Plc
| 0% | $228,758 6,750 shares@ $33.9 avg price | Exited |
IMTXImmatics N.v
| 0% | $182,434 15,700 shares@ $11.62 avg price | Exited |
BMEABiomea Fusion Inc
| 0% | $180,000 40,000 shares@ $4.5 avg price | Exited |
ABCLAbcellera Biologics Inc
| 0% | $150,874 50,971 shares@ $2.96 avg price | Exited |
KODKodiak Sciences Inc
| 0% | $75,017 31,922 shares@ $2.36 avg price | Exited |